PeterEvanDavisMD

Child Neurology • Boston, MA

Neurodevelopmental Disabilities

Child Neurologist at Boston Children's Hospital

Join to view full profile

Dr. Davis is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Davis' full profile

Already have an account?

Office
300 Longwood Ave
Mailstop BCH 3433
Boston, MA 02115
Phone+1 617-355-2711

Fax+1 617-730-0288

Summary

Dr. Peter Davis is a Child Neurologist in Boston, MA and is affiliated with Boston Children's Hospital. He received his medical degree from Warren Alpert Medical School of Brown University and has been in practice 7 years. He is experienced in tuberous sclerosis, child neurology, behavioral disorders, neurodevelopmental disabilities, and autism spectrum disorders.

Education & Training

Boston Children’s Hospital/Beth Israel Deaconess Medical Center/Harvard Medical SchoolFellowship, Child Neurology, 2015 - 2017
Boston Children’s Hospital/Beth Israel Deaconess Medical Center/Harvard Medical SchoolResidency, Child Neurology, 2012 - 2015
Montefiore Medical Center/Albert Einstein College of MedicineResidency, Pediatrics, 2010 - 2012
The Warren Alpert Medical School of Brown UniversityClass of 2010

Certifications & Licensure

MA State Medical License 2015 - 2026
NH State Medical License 2024 - 2024
American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology

Clinical Trials

Early Biomarkers of Autism in Infants With Tuberous Sclerosis Complex (TSC) Start of enrollment: 2013 Jan 01
Completed
Autism Spectrum Disorder (ASD) and Intellectual Disability (ID) Determinants in Tuberous Sclerosis Complex (TSC) Start of enrollment: 2015 May 01
Recruiting
Preventing Epilepsy Using Vigabatrin In Infants With Tuberous Sclerosis Complex Start of enrollment: 2016 Dec 01
Completed
Phase 2
RAD001 and Neurocognition in PTEN Hamartoma Tumor Syndrome Start of enrollment: 2017 Jun 12
Completed
Phase 1, Phase 2
Topical Sirolimus Ointment for Cutaneous Angiofibromas in Subjects With Tuberous Sclerosis Complex Start of enrollment: 2017 Apr 12
Terminated
Phase 2
Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention Study Start of enrollment: 2021 Oct 13
Recruiting
Phase 2
Basimglurant in Children, Adolescents, and Young Adults With TSC Start of enrollment: 2022 Mar 03
Recruiting
Phase 2
A Study to Evaluate the Safety and Efficacy of Basmisanil Treatment in Children Aged 2-14 Years With Dup15q Syndrome Start of enrollment: 2022 Dec 16
Terminated
Phase 2
Join now to see all

Publications & Presentations

PubMed

1 citations
Abnormality of Early White Matter Development in Tuberous Sclerosis Complex and Autism Spectrum Disorder: Longitudinal Analysis of Diffusion Tensor Imaging Measures.
Siddharth Srivastava, Fanghan Yang, Anna K Prohl, Peter E Davis, Jamie K Capal
Journal of Child Neurology. 2024-05-01
6 citations
Development and Feasibility of the Self-Report Quantified Tuberous Sclerosis Complex-Associated Neuropsychiatric Disorders Checklist (TAND-SQ).
Tosca-Marie Heunis, Nola Chambers, Stephanie Vanclooster, Stacey Bissell, Anna W Byars
Pediatric Neurology. 2023-10-01
8 citations
International consensus recommendations for the identification and treatment of tuberous sclerosis complex-associated neuropsychiatric disorders (TAND).
Petrus J de Vries, Tosca-Marie Heunis, Stephanie Vanclooster, Nola Chambers, Stacey Bissell
Journal of Neurodevelopmental Disorders. 2023-09-14

Journal Articles

The Spectrum of Movement Disorders in Childhood‐Onset Lysosomal Storage Diseases
Peter E Davis, Clara Hildebrandt, Irina Anselm, Lance H Rodan, Movement Disorders Clinical Practice